The Valley Desk

Clinical trial reportCancer communications (London, England)Published

A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the ovary, hypercalcemic type cohort

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Temple University Hospital, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Cancer communications (London, England)
Published
Subject terms
Humans; Carcinoma, Small Cell; Ovarian Neoplasms; Hypercalcemia; Disease Progression; Rare Diseases; Antineoplastic Combined Chemotherapy Protocols; Prospective Studies; Adult; Aged; Middle Aged; Female
PubMed ID
40402690
PubMed Central ID
PMC12365539
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal